The Clinical and Surgical Characteristics of Parotid Tumors with Parapharyngeal Space Involvement—A Multicenter Experience of the Polish Salivary Network
<b>Backgrounds/Objectives:</b> Parotid gland tumors (PGTs) with parapharyngeal space (PPS) involvement have a specific clinical course and they can be a great challenge for surgeons, especially due to more difficult approaches and the risk of serious complications. The aim of this study is to present the characteristics of PGTs with PPS involvement. <b>Methods</b>: Retrospective, multicenter analysis of 1954 primary PGTs from 5 years (2017-2021) was performed. Comparative analysis was performed between groups with and without PPS involvement and included the following clinical and histopathological data: age, sex, place of residence, tumor size, FNAC result, percentage of malignant tumors, histological diagnosis, radicality of resection, and postoperative facial nerve (FN) dysfunction. <b>Results:</b> PPS involvement was found in 114 patients (5.83%). Secondary tumors affecting the deep lobe or the entire gland were predominant (46 and 60 cases, respectively). In a univariate analysis of tumors with and without PPS involvement, statistically significant differences were found in their size > 4 cm (12.97% vs. 37.72%), percentage of malignant tumors (7.12% vs. 17.55%), incidence of Warthin Tumors (WTs) (43.58% vs. 24.56%), percentage of R1 resection (5.53% vs. 12.50%), and rate of FN paresis (17.15% vs. 53.34%). Multivariate analysis showed that tumors with PPS involvement were statistically significantly characterized by larger size (tumors > 4 cm were 2.9 times more frequent), 2 times less frequent occurrence of WTs, and 1.6 times higher risk of FN paresis. <b>Conclusion:</b> PGTs with PPS involvement show certain clinical and histological differences and require more complex surgical accesses. Therefore, they cannot be treated as "ordinary" tumors occupying the deep lobe.
Authors
- Patrycja Gazińska
- Izabela Olejniczak (ORCID: https://orcid.org/0000-0001-8676-0200)
- Antoni Bruzgielewicz (ORCID: https://orcid.org/0000-0002-9228-6346)
- Paweł Witkowski
- Małgorzata Wierzbicka (ORCID: https://orcid.org/0000-0003-0006-6352)
- Bogusław Mikaszewski (ORCID: https://orcid.org/0000-0002-2571-1824)
- Ewelina Bartkowiak (ORCID: https://orcid.org/0000-0003-3351-0923)
- Joanna Czech (ORCID: https://orcid.org/0000-0002-1449-4561)
- Jarosław Markowski (ORCID: https://orcid.org/0000-0003-3416-7354)
- Małgorzata Wierzchowska
- Katarzyna Radomska (ORCID: https://orcid.org/0000-0002-0464-1214)
- Wioletta Pietruszewska (ORCID: https://orcid.org/0000-0001-5109-3911)
- Paweł Burduk (ORCID: https://orcid.org/0000-0001-6653-4599)
- Dominik Stodulski (ORCID: https://orcid.org/0000-0002-4736-152X)
- Daniel Majszyk (ORCID: https://orcid.org/0000-0001-8802-7336)
- Alicja Chańko (ORCID: https://orcid.org/0009-0008-9733-4440)
- Aleksandra Piernicka-Dybich
Institutions
- Wrocław University of Science and Technology (PL)
- Poznan University of Medical Sciences (PL)
- Medical University of Silesia (PL)
- King's College London (GB)
- Medical University of Warsaw (PL)
- Nicolaus Copernicus University (PL)
- Institute of Human Genetics (PL)
- Medical University of Lodz (PL)
- Wroclaw Research Centre EIT+ (Poland) (PL)
- Łukasiewicz Research Network – PORT Polish Center for Technology Development (PL)
- AGH University of Krakow (PL)
- Gdańsk Medical University (PL)
- Pomeranian Medical University (PL)
- Polish Academy of Sciences (PL)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2024-08-05
- DOI
- https://doi.org/10.3390/jcm13154574
- Citations
- 3
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.72